{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:29:17Z","timestamp":1792384157830,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2023-JYB-JBZD-046"],"award-info":[{"award-number":["2023-JYB-JBZD-046"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322075"],"award-info":[{"award-number":["82322075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhep.2025.01.020","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T18:51:20Z","timestamp":1738695080000},"page":"52-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4"],"prefix":"10.1016","volume":"83","author":[{"given":"Xiaoyong","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-5252","authenticated-orcid":false,"given":"Runping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.01.020_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.01.020_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.01.020_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2014.11.027","article-title":"Autophagy and senescence in fibrosing cholangiopathies","volume":"62","author":"Nakanuma","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.020_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2025.01.020_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mam.2013.10.001","article-title":"Chronic cholestatic liver diseases: clues from histopathology for pathogenesis","volume":"37","author":"Pollheimer","year":"2014","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2025.01.020_bib6","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New treatment paradigms in primary biliary cholangitis","volume":"21","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.01.020_bib7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.020_bib8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.020_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.12560","article-title":"Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis","volume":"35","author":"Quarneti","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.01.020_bib10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.020_bib11","article-title":"Hyodeoxycholic acid derivatives as liver X receptor alpha and G-protein-coupled bile acid receptor agonists","volume":"7","author":"De Marino","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.jhep.2025.01.020_bib12","article-title":"A novel drug delivery system: hyodeoxycholic acid-modified metformin liposomes for type 2 diabetes treatment","volume":"28","author":"Hu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jhep.2025.01.020_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.omto.2021.07.012","article-title":"E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms","volume":"22","author":"Jiang","year":"2021","journal-title":"Mol Ther-Oncolytics"},{"key":"10.1016\/j.jhep.2025.01.020_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.07.020","article-title":"E1AF, an ets-oncogene family transcription factor","volume":"216","author":"Shindoh","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2025.01.020_bib15","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/hep.29738","article-title":"Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis","volume":"67","author":"Kim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.020_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2","volume":"79","author":"Xie","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.020_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.1451","article-title":"Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis","volume":"201","author":"Colombat","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2025.01.020_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04065-y","article-title":"Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A\/ETV4 axis","volume":"21","author":"Yu","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jhep.2025.01.020_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gpb.2012.12.002","article-title":"N6-methyl-adenosine (m6A) in RNA: an old modification with A novel epigenetic function","volume":"11","author":"Niu","year":"2013","journal-title":"Genomics, Proteomics & Bioinformatics"},{"key":"10.1016\/j.jhep.2025.01.020_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jhep.2025.01.020_bib21","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","article-title":"The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis","volume":"30","author":"Li","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2025.01.020_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1198","article-title":"ALKBH5-mediated m6A demethylation of TIRAP mRNA promotes radiation-induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma","volume":"13","author":"Chen","year":"2023","journal-title":"Clin Translational Med"},{"key":"10.1016\/j.jhep.2025.01.020_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125811","article-title":"N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation","volume":"248","author":"Chen","year":"2023","journal-title":"Int J Biol Macromolecules"},{"key":"10.1016\/j.jhep.2025.01.020_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m(6)A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2025.01.020_bib25","article-title":"The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jhep.2025.01.020_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury - what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.020_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","article-title":"Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.020_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/liv.12680","article-title":"Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"35","author":"Bell","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2025.01.020_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.020_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175891","article-title":"Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota","volume":"955","author":"Shen","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2025.01.020_bib31","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.01.020_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.jhep.2025.01.020_bib33","doi-asserted-by":"crossref","first-page":"1728-+","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.01.020_bib34","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170926","article-title":"PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of miR-34a and miR-29c in hepatic stellate cells","volume":"37","author":"Liu","year":"2017","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jhep.2025.01.020_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13690","article-title":"Myeloid cell-specific mutation of Spi1 selectively reduces M2-biased macrophage numbers in skeletal muscle, reduces age-related muscle fibrosis and prevents sarcopenia","volume":"21","author":"Wang","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.jhep.2025.01.020_bib36","article-title":"Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice","volume":"6","author":"Cooper","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2025.01.020_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.omtn.2021.08.019","article-title":"Essential role of ALKBH5-mediated RNA demethylation modification in bile acid-induced gastric intestinal metaplasia","volume":"26","author":"Yue","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jhep.2025.01.020_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejphar.2013.06.036","article-title":"Ileal apical sodium-dependent bile acid transporter protein levels are down-regulated through ubiquitin-dependent protein degradation induced by bile acids","volume":"714","author":"Miyata","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2025.01.020_bib39","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2217\/epi-2019-0365","article-title":"Dynamic analysis of m6A methylation spectroscopy during progression and reversal of hepatic fibrosis","volume":"12","author":"Cui","year":"2020","journal-title":"Epigenomics-Uk"},{"key":"10.1016\/j.jhep.2025.01.020_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102378","article-title":"The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis","volume":"54","author":"Sun","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2025.01.020_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102151","article-title":"N-6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells","volume":"47","author":"Shen","year":"2021","journal-title":"Redox Biol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:04:04Z","timestamp":1766192644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0168827825000558"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}